Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Minocycline as a Neuroimmune Therapy for Alcohol Use Disorder

NCT03244592 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT03244592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03244592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Minocycline as a Neuroimmune Therapy for Alcohol Use Disorder
Lead sponsor
University of California, Los Angeles
Phase
Phase 1/2
Overall status
Withdrawn
Start date
January 15, 2018
Completion date
March 1, 2018
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol drinking, alcohol use disorder, craving, inflammation, neurocognitive dysfunction